Context TherapeuticsCNTX
13F holders, Q1 2024 (March 31)25holders
2famous investors
$1.38avg. 13F price*
At the end of Q1 2024, 25 institutions reported holding Context Therapeutics Inc. (CNTX) in their 13F filings. The largest holders were Opaleye Management Inc. ($1.5M), Ally Bridge Group (NY) LLC ($1.0M) and Vanguard Group Inc. ($826K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Context Therapeutics Inc.
- CUSIP
- 21077P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $345K |
| Exits | 3 | $22K |
Ownership 25 holders
| Opaleye Management Inc. | 0.34% | Add +13.7% | 1,108,357 | $1.5M |
| Ally Bridge Group (NY) LLC | 0.56% | No change | 725,951 | $1.0M |
| Vanguard Group Inc. | 0.00% | Add +0.4% | 598,303 | $826K |
| Affinity Asset Advisors, LLC | 0.08% | No change | 328,817 | $454K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.01% | No change | 296,675 | $409K |
| ADAR1 Capital Management, LLC | 0.08% | New | 205,934 | $284K |
| HighTower Advisors, LLC | 0.00% | No change | 125,852 | $174K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 105,809 | $146K |
| Mill Creek Capital Advisors, LLC | 0.00% | No change | 104,631 | $144K |
| Geode Capital Management, LLC | 0.00% | Add +3.9% | 101,072 | $140K |
| Renaissance Technologies | 0.00% | Add +23.9% | 39,900 | $55K |
| Northern Trust Corp. | 0.00% | No change | 37,219 | $51K |
| Clear Harbor Asset Management, LLC | 0.00% | No change | 36,000 | $50K |
| State Street Corp. | 0.00% | No change | 32,907 | $45K |
| Susquehanna International Group, LLP | 0.00% | New | 22,389 | $31K |
| Sheets Smith Wealth Management | 0.00% | No change | 20,000 | $28K |
| Citadel Advisors | 0.00% | Reduce -5.3% | 15,041 | $21K |
| Jefferies Financial Group Inc. | 0.00% | New | 11,453 | $16K |
| XTX Topco Ltd | 0.00% | New | 10,261 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -4.5% | 6,357 | $9K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,500 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $552 |
| Retirement Group, LLC | 0.00% | No change | 155 | $214 |
| Wells Fargo & Company | 0.00% | Add +1.8% | 116 | $160 |
| JPMorgan Chase & Co. | 0.00% | Add +43.5% | 33 | $46 |
"% of holder's portfolio" is CNTX's weight in each manager's 13F, not the share of Context Therapeutics Inc. the manager owns.